Age Related Macular Degeneration May be Prevented with Macugen
Age-related macular degeneration (AMD) is the leading cause of blindness in older patients in US and the developed world. Pegaptanib sodium (Macugen) is a new treatment for exudative AMD, and has been shown to stabilize vision in approximately 70 percent of cases.
The researchers found that at week 54, 76 percent of patients in group 1 receiving pegaptanib lost fewer than 15 letters or three lines of vision on the ETDRS eye chart, compared with 50 percent of patients undergoing usual care. A number of patients treated with pegaptanib even regained some sight.
The study found that early detection and treatment of age-related macular degeneration with pegaptanib sodium may enable AMD patients to maintain and, in some cases, regain vision.
As a result, the Jules Stein Eye Institute is launching a prospective, open-label, multi-center trial to evaluate the efficacy and safety of pegaptanib in 40 patients with early onset of AMD.
Filed under Eye Treatment, Macular Degeneration
You may also like to read
- Hope for Age Related Macular Degeneration with Lucentis
- Macular Degeneration and its New Treatments
- Age-Related Macular Degeneration Can Be Avoided By Taking Nutrients
- Phase-II Clinical Trial of Drug Evizon for Wet Age-Related Macular Degeneration
- Routine activation of immune system protein TLR3 triggers Macular degeneration
- Eye Drug Lucentis Recommended by UK's NICE to Treat Wet AMD
- Midwest Eye Institute Doctor Helps To Test Drug For Macular Degeneration
- Free Check for Eye Diseases ( Diabetic Retinopathy & Macular Degeneration )
- Incurable Age-Related Macular Degeneration Loom for Smokers
- New study indicate Omega-3 Fatty Acids reduces and prevent the risk of AMD
October 29th, 2007 at 4:44 pm
My father, who is 80 years old, has MD. We have sought every area of help available, and it simply is what it is. However, I wonder if you know of any support groups, groups to assist in finding activities or ways of attending activities without becoming frustrated and choosing to stay inside.